Current filters:  
Argentina
Life Sciences, Biotechnology & Nanotechnology
Argentina
Moeller IP Advisors
In June, the United States Trade Representative´s Office (USTR) issued an official report entitled "Special 301 Report," which highlighted the different problems that both U.S. Government...
Clarke, Modet & Co
Buenos Aires, 8 de noviembre de 2016.- Clarke Modet & Cº Argentina anuncia los ganadores de su Premio al Periodismo de Divulgación Científica y Tecnológica 2016 e invita a la entrega del galardón, a realizarse el próximo 30 de noviembre en la ciudad de Córdoba.
Moeller IP Advisors
In May 2016, FDA sent the second warning letter to the Argentinian manufacturing medical device company.
Moeller IP Advisors
The Colombian Ministry of Health, through its Minister Alejandro Gaviria, seeks to declare the drug product Glivec® of public interest, meaning it would improve the well-being of the general population.
Moeller IP Advisors
On May 11, 2016 the Brazilian government published Decree No. 8,772, which regulates Law No. 13,123/2015, related to the access of components of the Brazilian genetic heritage...
Moeller IP Advisors
The Costa Rican Ministry of Health warned the general public about counterfeit medicine discovered in Guatemala under a Resolution dated May 10, 2016.
Moeller IP Advisors
The future is coming to Latin America. Does your business have the expertise to everything that comes with it? Beyond the technical know-how and capital to innovate in the biotech sector...
Clarke, Modet & Co
Clarke, Modet & Co Argentina convoca a periodistas y divulgadores a participar de la sexta edición de su "Premio al Periodismo sobre Divulgación Científica y Tecnológica".
Clarke, Modet & Co
Latin America is undergoing important economic and political changes. This has an effect in the Protection of IP Rights.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media